Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1954 5
1955 4
1958 2
1960 3
1961 3
1965 6
1966 10
1967 14
1968 19
1969 17
1970 26
1971 18
1972 31
1973 20
1974 31
1975 39
1976 28
1977 49
1978 31
1979 23
1980 25
1981 22
1982 31
1983 72
1984 81
1985 99
1986 110
1987 111
1988 142
1989 205
1990 185
1991 175
1992 240
1993 235
1994 257
1995 245
1996 257
1997 243
1998 331
1999 285
2000 351
2001 494
2002 498
2003 499
2004 577
2005 669
2006 642
2007 764
2008 922
2009 945
2010 1101
2011 1226
2012 1375
2013 1495
2014 1684
2015 1720
2016 1589
2017 1633
2018 1679
2019 1823
2020 2397
2021 2819
2022 2543
2023 2518
2024 1412

Search Results

32,959 results

Results by year

Filters applied: . Clear all
Page 1
Introduction: hepatocellular carcinoma.
Carr BI. Carr BI. Semin Oncol. 2012 Aug;39(4):367-8. doi: 10.1053/j.seminoncol.2012.06.001. Semin Oncol. 2012. PMID: 22846854 No abstract available.
Advances in Hepatocellular Carcinoma.
Frenette C. Frenette C. Clin Liver Dis. 2020 Nov;24(4):xiii-xiv. doi: 10.1016/j.cld.2020.08.014. Clin Liver Dis. 2020. PMID: 33012459 No abstract available.
Evolving therapeutic landscape of advanced hepatocellular carcinoma.
Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W, Wang C. Yang C, et al. Nat Rev Gastroenterol Hepatol. 2023 Apr;20(4):203-222. doi: 10.1038/s41575-022-00704-9. Epub 2022 Nov 11. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36369487 Review.
Management of hepatocellular carcinoma: an update.
Bruix J, Sherman M; American Association for the Study of Liver Diseases. Bruix J, et al. Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199. Hepatology. 2011. PMID: 21374666 Free PMC article. No abstract available.
Liver-directed therapy for hepatocellular carcinoma.
Narsinh KH, Duncan DP, Newton IG, Minocha J, Rose SC. Narsinh KH, et al. Abdom Radiol (NY). 2018 Jan;43(1):203-217. doi: 10.1007/s00261-017-1435-6. Abdom Radiol (NY). 2018. PMID: 29230556 Review.
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.
Scheiner B, Pomej K, Kirstein MM, Hucke F, Finkelmeier F, Waidmann O, Himmelsbach V, Schulze K, von Felden J, Fründt TW, Stadler M, Heinzl H, Shmanko K, Spahn S, Radu P, Siebenhüner AR, Mertens JC, Rahbari NN, Kütting F, Waldschmidt DT, Ebert MP, Teufel A, De Dosso S, Pinato DJ, Pressiani T, Meischl T, Balcar L, Müller C, Mandorfer M, Reiberger T, Trauner M, Personeni N, Rimassa L, Bitzer M, Trojan J, Weinmann A, Wege H, Dufour JF, Peck-Radosavljevic M, Vogel A, Pinter M. Scheiner B, et al. J Hepatol. 2022 Feb;76(2):353-363. doi: 10.1016/j.jhep.2021.09.035. Epub 2021 Oct 12. J Hepatol. 2022. PMID: 34648895 Free article.
Hepatocellular carcinoma.
El-Serag HB. El-Serag HB. N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683. N Engl J Med. 2011. PMID: 21992124 Review. No abstract available.
32,959 results
You have reached the last available page of results. Please see the User Guide for more information.